Sanofi-Aventis sees lower 2011 earnings

French drugs giant Sanofi-Aventis says talks with its takeover target U.S biotech Genzyme are ongoing, further extending months of suspense surrounding the deal as it forecast an earnings decline this year of between 5%-10%.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.